Curasight A/S (NGM: CURAS)
Health Care · Biotechnology · DK
Dkr—
— today · — 1Y
Curasight A/S (NGM: CURAS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $66.59M.
trading between 3.80 and 25.00.
Tweenvest scores Curasight A/S across four factors: quality 34/100, value 47/100. Its strongest factor is value.
CURAS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $66.59M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.11
- Dividend yield
- —
- Beta (5Y)
- 0.41
- 52-week high
- Dkr25.00
- 52-week low
- Dkr3.80
- Avg volume (3M)
- —
- Shares outstanding
- 49.46M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Libo Pharma Corp.TPEX: 7888 | $68.06M | NT$29.35 | -3.77% |
| Artgen Biotech PJSCMISX: ISKJ | $68.01M | RUB— | — |
| MAIA Biotechnology, Inc.NYSEAM: MAIA | $66.91M | $1.10 | -9.84% |
| BIO-FD&C Co.,Ltd.KOSDAQ: A251120 | $66.79M | ₩10,240.00 | +1.19% |
| Bonus BioGroup Ltd.TASE: BONS | $66.29M | ₪0.18 | +2.92% |
| Lytix Biopharma ASAOB: LYTIX | $65.15M | Nkr8.00 | -2.44% |
| StemRIMTSE: 4599 | $65.11M | ¥164.00 | -6.29% |
| CORESTEMCHEMON Inc.KOSDAQ: A166480 | $64.85M | ₩1,949.00 | -16.71% |
Figures last refreshed Oct 18, 2026.